Literature DB >> 320261

Immunologic characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants. I. Cellular analysis of immunosuppression.

N Haran-Ghera, M Ben-Yaakov, A Peled.   

Abstract

Infection of adult C57BL/6 mice with variants of the radiation leukemia virus resulted in variable leukemia incidence. One variant, designated D-RadLV, induced lymphatic leukemia in 0 to 25% of mice after virus inoculation directly into the thymus of young adult mice. The leukemia incidence could be increased to 80 to 100% by host exposure to x-rays. The second variant, A-RadLV, induced lymphatic leukemia in 80 to 100% of similarly inoculated mice without the need for additional radiation treatment. Adult mice were inoculated with D-radLV or A-RadLV. Both variants reduced the immune response to sheep erythrocytes whereas only D-RadLV had an immunosuppressive effect after immunization with a thymus-independent immunogen polyvinyl-pyrrolidone (PVP). Results of transfer experiments indicated that the immunosuppressive effects were expressed at the immunocompetent cell level. Thymus-derived cells were affected by A-RadLV since their immunocompetent function was impaired, whereas D-RadLV affected the marrow cell population of immunocytes. Exposure of D-RadLV-inoculated mice to x-rays induced functional impairment of both thymus and marrow cells. Since the radiation leukemia virus induces "T" lymphatic leukemia it could be proposed that the initial tropism of the virus to thymocytes would lead to high leukemia induction potential, whereas virus tropism to bone marrow cells would yield a low leukemia incidence. The coleukemogenic effect of x-rays could perhaps be related with its capacity to alter and introduce a change in virus-lymphoid cells interaction.

Entities:  

Mesh:

Year:  1977        PMID: 320261

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Promotion of tumor antigenicity in EL-4 leukemia cells by hydrostatic pressure.

Authors:  L Richert; A Or; M Shinitzky
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Prothymocytes as target cells of T cell leukemogenesis in the mouse.

Authors:  N Haran-Ghera
Journal:  Surv Immunol Res       Date:  1985

Review 3.  Role of the major histocompatibility complex in resistance to viral leukemia; its effect on the preleukemic stage of leukemogenesis.

Authors:  P Lonai; E Katz; N Haran-Ghera
Journal:  Springer Semin Immunopathol       Date:  1982

4.  Expression of peanut agglutinin receptors on virus-induced preleukemic cells in mice.

Authors:  Y Reisner; N Sharon; N Haran-Ghera
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

5.  I-region linked complementing loci in resistance to viral leukemogenesis in the mouse.

Authors:  P Lonai; E Katz; N Haran-Ghera
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

6.  In vitro generation of cytotoxic lymphocytes against radiation- and radiation leukemia virus-induced tumors. III. Suppression of anti-tumor immunity in vitro by lymphocytes of mice undergoing radiation leukemia virus-induced leukemogenesis.

Authors:  E Yefenof; A Meidav; E Kedar
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

7.  Genetic resistance to murine leukemia induced by different radiation leukemia virus variants; a comparative study on the role of the H-2 complex.

Authors:  P Lonai; N Haran-Ghera
Journal:  Immunogenetics       Date:  1980-07       Impact factor: 2.846

8.  Role of pineal melatonin and melatonin-induced-immuno-opioids in murine leukemogenesis.

Authors:  A Conti; N Haran-Ghera; G J Maestroni
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

9.  Suppressor and reactive lymphocytes in radiation leukemia virus (RadLV)-induced leukemogenesis.

Authors:  E Yefenof; Y Ben-David
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

10.  Treatment of premalignancy: prevention of lymphoma in radiation leukemia virus-inoculated mice by cyclosporin A and immunotoxin.

Authors:  E Yefenof; G Abboud; S Epszteyn; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.